CG
BIB icon

Cutler Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Cutler Group’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-400
Closed -$20.6K – 3786
2023
Q2 		$20K Buy
+400
New +$22K ﹤0.01% 1839
2023
Q1 		– Sell
-1,456
Closed -$82.2K – 3808
2022
Q4 		$84K Buy
1,456
+538
+59% +$30.3K 0.01% 1268
2022
Q3 		$43K Buy
918
+500
+120% +$26.6K ﹤0.01% 1998
2022
Q2 		$20K Buy
418
+18
+5% +$916 ﹤0.01% 2661
2022
Q1 		$24K Buy
400
+100
+33% +$6.14K ﹤0.01% 2883
2021
Q4 		$24K Sell
300
-700
-70% -$60K ﹤0.01% 2974
2021
Q3 		$94K Buy
1,000
+100
+11% +$10.1K ﹤0.01% 1962
2021
Q2 		$88K Buy
+900
New +$78.5K ﹤0.01% 1990
2021
Q1 		– Sell
-26
Closed -$2.45K – 5628
2020
Q4 		$2K Hold
26
– – ﹤0.01% 4107
2020
Q3 		$1K Sell
26
-100
-79% -$7.09K ﹤0.01% 4252
2020
Q2 		$9K Buy
+126
New +$8.05K ﹤0.01% 2920
2020
Q1 		– Sell
-926
Closed -$51.6K – 4017
2019
Q4 		$57K Buy
+926
New +$49.4K ﹤0.01% 1539
2019
Q3 		– Sell
-1,476
Closed -$70K – 4072
2019
Q2 		$76K Buy
+1,476
New +$73.4K 0.01% 1254
2019
Q1 		– Sell
-399
Closed -$21.5K – 4038
2018
Q4 		$16K Buy
+399
New +$20.8K ﹤0.01% 2245
2018
Q2 		– Sell
-227
Closed -$12.4K – 4196
2018
Q1 		$12K Buy
227
+101
+80% +$6.05K ﹤0.01% 2627
2017
Q4 		$7K Buy
+126
New +$7.11K ﹤0.01% 3366
2017
Q3 		– Sell
-100
Closed -$5.69K – 5849
2017
Q2 		$5K Hold
100
– – ﹤0.01% 4794
2017
Q1 		$4K Buy
+100
New +$4.65K ﹤0.01% 4851
2016
Q4 		– Sell
-270
Closed -$11.5K – 6501
2016
Q3 		$13K Sell
270
-1,530
-85% -$72.7K ﹤0.01% 3874
2016
Q2 		$69K Buy
+1,800
New +$77.6K ﹤0.01% 2033

Other funds holding BIB

TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Cutler Group's BIB Position: Q3 2023 in Review

Cutler Group sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q3 2023, closing a stake of 400 shares — an estimated $20.6K sold.

Cutler Group first reported a position in BIB in Q2 2016 and held it in 20 quarters. The position peaked at $94K in Q3 2021. 21 funds tracked by Wall St. Rank hold BIB as of Q3 2023.

  • Cutler Group reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 400 ProShares Ultra NASDAQ Biotechnology shares in Q3 2023, an estimated $20.6K.
  • Cutler Group first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2016 and held it in 20 quarters.
  • Cutler Group's ProShares Ultra NASDAQ Biotechnology position peaked at $94K in Q3 2021.
  • 21 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.